Alumis ALMS
NASDAQ ALMS
$6.86 +0.16 (+2.31%)
As of: Oct 21, 2026 · 11:38 AM EDT

Alumis (ALMS) EBITDA Margin (2025)

Updated

Alumis (ALMS) posted EBITDA Margin of -4954.80% for Q4 2025, up 581.31 percentage points from the prior quarter.

Analysis

Alumis (ALMS) EBITDA Margin (2025) Analysis & Trends

For FY2025, Alumis' EBITDA Margin came in at -1872.38%.

  • Quarterly EBITDA Margin has run from a low of -5536.11% in Q3 2025 to a high of -578.65% in Q1 2025 over five years.
  • According to Business Quant data, EBITDA Margin for the three prior quarters was -5536.11% (Q3 2025), -5238.90% (Q2 2025) and -578.65% (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn 53.49%
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn 35.95%
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn 49.01%
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn 6.02%
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn -
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn 33.11%
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn 46.01%
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn -124.26%
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn 39.16%
10 Alumis 878.57 Mn -796.27 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -4,954.80%
Sep 30, 2025 -5,536.11%
Jun 30, 2025 -5,238.90%
Mar 31, 2025 -578.65%
API Access

Alumis EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ALMS&period=max&api_key=YOUR_API_KEY